Home » Medical Devices » Structural Heart Devices Market

Structural Heart Devices Market By Product (Heart Valve Devices: Surgical Heart Valves, Transcatheter Heart Valves, Annuloplasty Rings, Occluders and Delivery Systems, Other Products); By Procedure (Replacement Procedures: Surgical Aortic Valve Replacement (SAVR), Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Replacement (TMVR), Other Replacement Procedures; Repair Procedures: Left Atrial Appendage Closure (LAAC), Transcatheter Mitral Valve Repair (TMVr), Transcatheter Tricuspid Valve Repair (TTVr), Valvuloplasty, Other Repair Procedures); By End-use (Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Labs, Other End Use) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Name: Structural Heart Devices Market - Demand, Size and Competitive Analysis
Creator: Credence Research Inc.
Published: 2025-06-28
License: https://www.credenceresearch.com/info/privacy-policy
Keywords: Structural Heart Devices Market

Summary
Table Of Content
Request Sample

REPORT ATTRIBUTE	DETAILS
Historical Period	2020-2023
Base Year	2024
Forecast Period	2025-2032
Structural Heart Devices Market Size 2024	USD 6,683.01 million
Structural Heart Devices Market, CAGR	8.65%
Structural Heart Devices Market Size 2032	USD 12,931.90 million

Market Overview

The Structural Heart Devices market size was valued at USD 5,210.00 million in 2018, reached USD 6,683.01 million in 2024, and is anticipated to reach USD 12,931.90 million by 2032, at a CAGR of 8.65% during the forecast period.

The Structural Heart Devices market is led by top players such as Abbott, Medtronic, Boston Scientific, Edwards Lifesciences, and LivaNova, all of which hold strong positions due to their extensive product portfolios, technological advancements, and global distribution networks. These companies focus heavily on innovation in transcatheter solutions and minimally invasive procedures to meet growing clinical demands. Other notable contributors like AtriCure, BIOMERICS, JENAVALVE, LEPU Medical, CryoLife, and NUMED are strengthening the competitive landscape through niche offerings and regional market expansions. North America dominates the global market with a commanding share of approximately 40.8% in 2024, driven by advanced healthcare infrastructure, high adoption rates of innovative devices, and increasing procedure volumes.

Market Insights

The Structural Heart Devices market was valued at USD 6,683.01 million in 2024 and is projected to reach USD 12,931.90 million by 2032, growing at a CAGR of 8.65% during the forecast period.
The market is driven by the rising prevalence of structural heart diseases and increasing demand for minimally invasive procedures like Transcatheter Aortic Valve Replacement (TAVR), which holds a dominant segment share.
Key trends include technological advancements, increasing regulatory approvals, and growing adoption of transcatheter heart valves, supported by integrated imaging and navigation technologies.
The competitive landscape is shaped by major players such as Abbott, Medtronic, Boston Scientific, Edwards Lifesciences, and LivaNova, who focus on product innovation, partnerships, and geographic expansion to strengthen their market positions.
North America leads the market with 40.8% share in 2024, followed by Europe at 24.6%, while Asia Pacific emerges as the fastest-growing region with a 10.0% CAGR and increasing healthcare investments.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research Inc.!

Download Sample

Market Segmentation Analysis:

By Product

The Structural Heart Devices market, by product, is predominantly led by Heart Valve Devices, which hold the largest market share. Within this category, Transcatheter Heart Valves have emerged as the dominant sub-segment due to their minimally invasive nature and growing preference over surgical alternatives, particularly among high-risk and elderly patients. Technological advancements and increased adoption of transcatheter techniques have significantly driven this segment’s growth. Annuloplasty Rings and Occluders and Delivery Systems also contribute notably, especially with the rising number of mitral valve repair procedures and increasing cases of congenital heart defects requiring occlusion therapies.

For instance, Edwards Lifesciences’ SAPIEN 3 Transcatheter Heart Valve has been implanted in over 600,000 patients worldwide, demonstrating the extensive adoption of transcatheter heart valves.

By Procedure

The Replacement Procedures segment holds the largest market share, with Transcatheter Aortic Valve Replacement (TAVR) dominating this space. The popularity of TAVR is fueled by its minimally invasive approach, faster recovery times, and expanding indications for lower-risk patient groups. Surgical Aortic Valve Replacement (SAVR) and Transcatheter Mitral Valve Replacement (TMVR) also contribute but are witnessing slower growth compared to TAVR. The Repair Procedures segment is steadily expanding, driven by the increasing prevalence of mitral and tricuspid regurgitation. Procedures such as Left Atrial Appendage Closure (LAAC) and Transcatheter Mitral Valve Repair (TMVr) are gaining traction due to advancements in device technology and growing awareness of stroke prevention strategies.

For instance, Medtronic reported that more than 250,000 CoreValve Evolut systems have been successfully implanted globally, underscoring the dominance of TAVR procedures

By End-use

Hospitals dominate the Structural Heart Devices market, accounting for the largest market share. This dominance is attributed to the availability of advanced cardiac care infrastructure, skilled healthcare professionals, and the growing number of complex structural heart interventions performed in hospital settings. Cardiac Catheterization Labs are emerging as a rapidly growing segment, driven by the increasing shift towards transcatheter procedures and outpatient cardiac care. Ambulatory Surgical Centers are gaining momentum due to the rising demand for cost-effective, minimally invasive treatments that offer shorter hospital stays and quicker patient turnaround.

Market Overview

Rising Prevalence of Structural Heart Diseases

The increasing global burden of structural heart diseases, particularly valvular heart disorders and congenital heart defects, is a significant growth driver for the Structural Heart Devices market. Aging populations are especially prone to these conditions, leading to higher demand for advanced treatment options. The rise in lifestyle-related risk factors such as hypertension, obesity, and diabetes further contributes to the growing patient pool. This steady increase in disease prevalence is compelling healthcare providers to adopt innovative structural heart devices, boosting market expansion.

For instance, Abbott’s Amplatzer Occluder devices have been used in over 1,000,000 patients to close congenital heart defects, supporting the response to rising disease prevalence.

Advancements in Minimally Invasive Procedures

Technological innovations have transformed the treatment landscape by enabling minimally invasive procedures like transcatheter valve replacements and repairs. These procedures offer reduced recovery times, lower procedural risks, and are increasingly preferred for elderly and high-risk patients. The growing acceptance of transcatheter techniques, such as TAVR and TMVR, over traditional surgical interventions has significantly accelerated market growth. Additionally, continuous device improvements and operator expertise are further driving the shift towards less invasive treatment options in structural heart care.

For instance, Boston Scientific’s WATCHMAN Left Atrial Appendage Closure Device has been implanted in more than 300,000 patients globally, showcasing the rapid advancement and acceptance of minimally invasive heart procedures.

Expanding Regulatory Approvals and Clinical Indications

The Structural Heart Devices market is benefiting from increasing regulatory approvals for new devices and expanded clinical indications for existing technologies. Companies are consistently securing approvals for transcatheter devices for broader patient categories, including intermediate and low-risk groups. This regulatory progress is enabling earlier intervention and is enhancing patient access to advanced therapies. The ongoing development of clinical evidence supporting the safety and efficacy of these devices continues to drive their adoption across healthcare settings globally.

Key Trends & Opportunities

Integration of Imaging and Navigation Technologies

A key trend in the Structural Heart Devices market is the growing integration of advanced imaging and navigation systems during transcatheter procedures. Real-time 3D imaging and improved catheter-based navigation tools are enhancing procedural accuracy and patient outcomes. This technological convergence not only improves surgical precision but also reduces the risk of complications. It presents a significant opportunity for device manufacturers to develop integrated systems that combine diagnostic and interventional capabilities, further strengthening their market position.

For instance, GE HealthCare’s Vivid E95 system, which features cSound image reconstruction and True Volume 4D imaging, has been adopted in over 2,500 cardiac centers worldwide to support real-time transcatheter procedures with improved precision.

Growth Potential in Emerging Markets

Emerging markets, particularly in Asia-Pacific and Latin America, offer substantial growth opportunities for the Structural Heart Devices market. Increasing healthcare investments, rising awareness of minimally invasive treatments, and improving access to advanced cardiac care are driving market expansion in these regions. Additionally, the rising middle-class population and growing prevalence of cardiovascular diseases in developing countries are creating new demand channels. Companies focusing on affordable solutions and local partnerships are well-positioned to capitalize on these emerging market trends.

For instance, Lepu Medical has established over 10 regional manufacturing facilities and more than 300 sales offices across China and Southeast Asia to expand structural heart device accessibility in emerging markets

Key Challenges

High Cost of Structural Heart Devices and Procedures

One of the major challenges facing the Structural Heart Devices market is the high cost associated with these advanced devices and their related procedures. Transcatheter interventions, although less invasive, involve expensive devices, specialized equipment, and highly skilled operators, limiting their accessibility in cost-sensitive regions. The substantial financial burden on patients and healthcare systems may slow down widespread adoption, particularly in developing economies with limited reimbursement support and budget constraints.

Stringent Regulatory Approval Processes

The market is also challenged by the complex and time-intensive regulatory approval processes required for new structural heart devices. Obtaining regulatory clearance involves rigorous clinical trials, long evaluation periods, and substantial investment in research and development. Delays in approval can hinder timely product launches and market expansion. Additionally, meeting evolving safety and efficacy standards across different regions creates significant hurdles for manufacturers seeking global market penetration.

Procedural and Device-Related Complications

Despite technological advancements, procedural and device-related complications remain a critical concern in the Structural Heart Devices market. Risks such as device malfunction, leakage, and incorrect placement can lead to adverse patient outcomes, deterring both physicians and patients from adopting newer interventions. Ensuring consistent operator training and improving device designs to minimize these risks is essential for sustaining long-term market growth and gaining broader clinical acceptance.

Regional Analysis

North America

North America holds the largest share in the Structural Heart Devices market, accounting for approximately 40.8% of the global market in 2024, with a market size of USD 2,728.17 million, up from USD 2,146.52 million in 2018. The market is projected to reach USD 5,302.79 million by 2032, expanding at a CAGR of 8.7% during the forecast period. The region’s dominance is driven by advanced healthcare infrastructure, high adoption of minimally invasive procedures, and increasing approvals for innovative transcatheter devices. A growing geriatric population further supports the demand for structural heart interventions across North America.

Europe

Europe commands a significant share of the Structural Heart Devices market, representing approximately 24.6% of the global market in 2024, with a market size of USD 1,642.50 million, rising from USD 1,333.76 million in 2018. The market is expected to grow to USD 2,971.40 million by 2032, at a steady CAGR of 7.7%. The increasing prevalence of valvular heart diseases, combined with a strong regulatory environment supporting early adoption of advanced medical technologies, fuels market growth in this region. Additionally, well-established cardiac centers and favorable reimbursement structures contribute to Europe’s continued market expansion.

Asia Pacific

The Asia Pacific Structural Heart Devices market is the fastest-growing region, with a CAGR of 10.0% and a market share of approximately 21.9% in 2024. The market size increased from USD 1,088.37 million in 2018 to USD 1,468.56 million in 2024, and it is expected to reach USD 3,153.04 million by 2032. Growth is driven by rising cardiovascular disease prevalence, increasing healthcare investments, and growing awareness of minimally invasive procedures. Rapid technological adoption in countries like China, Japan, and India, coupled with improving access to advanced cardiac care, significantly supports regional market growth.

Latin America

Latin America holds a smaller but growing share of approximately 6.1% in the Structural Heart Devices market in 2024, with the market size rising from USD 318.85 million in 2018 to USD 404.92 million in 2024. The region is projected to reach USD 731.56 million by 2032, growing at a CAGR of 7.8%. Market growth is supported by improving healthcare infrastructure, rising investments in cardiac care, and increasing awareness of minimally invasive treatment options. Brazil and Mexico lead the adoption of structural heart devices, driven by an expanding middle class and growing demand for advanced cardiac interventions.

Middle East

The Middle East Structural Heart Devices market accounted for around 3.4% of the global share in 2024, with the market size growing from USD 192.77 million in 2018 to USD 231.19 million in 2024. The market is expected to reach USD 408.56 million by 2032, advancing at a CAGR of 7.5%. Growth in this region is driven by increasing government investments in healthcare modernization and a growing prevalence of lifestyle-related heart conditions. Countries like Saudi Arabia and the UAE are leading markets, supported by the development of state-of-the-art cardiac centers and an increasing focus on minimally invasive cardiac procedures.

Africa

Africa represents the smallest regional share in the Structural Heart Devices market, contributing approximately 3.1% of the global market in 2024. The market expanded from USD 129.73 million in 2018 to USD 207.66 million in 2024, and it is expected to reach USD 364.55 million by 2032, growing at a CAGR of 7.4%. Although the market is in its nascent stage, improving healthcare access, rising awareness of heart diseases, and increasing partnerships with international medical device companies are fostering growth. South Africa remains a key contributor, with gradual improvements in cardiac care availability across other parts of the continent.

Market Segmentations:

By Product

Heart Valve Devices
- Surgical Heart Valves
- Transcatheter Heart Valves
Annuloplasty Rings
Occluders and Delivery Systems
Other Products

By Procedure

Replacement Procedures
- Surgical Aortic Valve Replacement (SAVR)
- Transcatheter Aortic Valve Replacement (TAVR)
- Transcatheter Mitral Valve Replacement (TMVR)
- Other Replacement Procedures
Repair Procedures
- Left Atrial Appendage Closure (LAAC)
- Transcatheter Mitral Valve Repair (TMVr)
- Transcatheter Tricuspid Valve Repair (TTVr)
- Valvuloplasty
- Other Repair Procedures

By End-use

Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs
Other End Use

By Geography:

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa

Competitive Landscape

The Structural Heart Devices market is highly competitive, with several key players actively focusing on innovation, strategic collaborations, and geographic expansion to strengthen their market positions. Major companies such as Abbott, Medtronic, Boston Scientific, Edwards Lifesciences, and LivaNova dominate the landscape, driven by extensive product portfolios and continuous investments in research and development. These players are introducing advanced transcatheter devices and minimally invasive solutions to address evolving clinical needs and patient preferences. Strategic acquisitions and partnerships are prevalent, enabling companies to enhance their technological capabilities and expand their global reach. Additionally, companies are increasingly focusing on securing regulatory approvals and expanding indications for existing devices to capture a broader patient base. This competitive environment encourages continuous product innovation and pushes manufacturers to improve procedural safety, efficacy, and accessibility across developed and emerging markets.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

Abbott
AtriCure
BIOMERICS
Boston Scientific
BRAILE
CryoLife
Edwards
JENAVALVE
LEPU MEDICAL
LivaNova
Medtronic
NUMED

Recent Developments

In March 2024, Medtronic (UK) received product approval for its EvolutFX+ transcatheter aortic valve replacement systems for the treatment of symptomatic severe aortic stenosis.
In August 2024, Edwards Lifesciences Corporation acquired JenaValve Technology (UK), a pioneer in the transcatheter treatment of aortic regurgitation, thereby strengthening its product portfolio.
In January 2024, Integer Holdings Corp. finalized a deal to acquire Pulse Technologies, a privately held contract manufacturing company that specializes in materials and coatings used to develop and manufacture medical devices to serve healthcare markets such as structural heart disease, electrophysiology, leadless pacing and neuromodulation.
In January 2023, Abbott (US) received product approval for Navitor, the only self-expanding TAVI system.
In June 2023, Teleflex (US) received product approval for Wattson Temporary pacing guidewire which is used for TAVR and balloon aortic valvuloplasty.
In December 2023, Edwards Lifesciences announced to spin off its critical care unit at the end of 2024 to concentrate on its larger heart devices business. Transcatheter aortic valve replacement (TAVR) device, the company’s lead product, has been facing rising competition from Abbott, Boston Scientific, and Medtronic. The device is used to perform minimally invasive surgery for people with heart valve disease.

Market Concentration & Characteristics

The Structural Heart Devices Market exhibits a moderately high market concentration, dominated by a few major players such as Abbott, Medtronic, Boston Scientific, Edwards Lifesciences, and LivaNova. These companies hold significant market shares and consistently introduce advanced products to maintain their leadership. It is highly characterized by continuous technological advancements, strong regulatory frameworks, and a growing preference for minimally invasive procedures. The market shows a steady shift toward transcatheter devices, particularly Transcatheter Aortic Valve Replacement (TAVR), which holds a leading segment position. Companies compete by expanding product portfolios, securing regulatory approvals, and enhancing global reach through strategic partnerships. It remains dynamic, with smaller players entering specific niches and larger companies focusing on broadening their indications and improving procedural outcomes. Pricing pressures, high development costs, and stringent regulatory processes create barriers for new entrants. It displays strong regional concentration in North America and Europe, while Asia Pacific rapidly grows, offering significant opportunities for market expansion.

Report Coverage

The research report offers an in-depth analysis based on Product, Procedure, End-use and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The Structural Heart Devices Market is expected to witness steady growth driven by increasing adoption of minimally invasive procedures.
Rising awareness and early diagnosis of structural heart diseases will continue to support market expansion.
Transcatheter heart valve devices will maintain a dominant position due to growing clinical acceptance and improved patient outcomes.
Integration of advanced imaging and navigation technologies will enhance precision and safety in structural heart procedures.
Companies will focus on expanding clinical indications to include lower-risk and younger patient populations.
Emerging markets, especially in Asia Pacific and Latin America, will present significant growth opportunities.
The development of next-generation devices with improved durability and reduced complications will remain a key priority.
Competitive strategies will increasingly involve collaborations, mergers, and acquisitions to strengthen market presence.
Regulatory approvals will continue to shape product availability and influence regional market dynamics.
Hospitals and cardiac catheterization labs will remain primary end-use settings, driven by rising procedure volumes and technological advancements.

CHAPTER NO. 1 :GENESIS OF THE MARKET

1.1 Market Prelude – Introduction & Scope

1.2 The Big Picture – Objectives & Vision

1.3 Strategic Edge – Unique Value Proposition

1.4 Stakeholder Compass – Key Beneficiaries

CHAPTER NO. 2 : EXECUTIVE LENS

2.1 Pulse of the Industry – Market Snapshot

2.2 Growth Arc – Revenue Projections (USD Million)

2.3. Premium Insights – Based on Primary Interviews

CHAPTER NO. 3 : STRUCTURAL HEART DEVICES MARKET FORCES & INDUSTRY PULSE

3.1 Foundations of Change – Market Overview

3.2 Catalysts of Expansion – Key Market Drivers

3.2.1 Momentum Boosters – Growth Triggers

3.2.2 Innovation Fuel – Disruptive Technologies

3.3 Headwinds & Crosswinds – Market Restraints

3.3.1 Regulatory Tides – Compliance Challenges

3.3.2 Economic Frictions – Inflationary Pressures

3.4 Untapped Horizons – Growth Potential & Opportunities

3.5 Strategic Navigation – Industry Frameworks

3.5.1 Market Equilibrium – Porter’s Five Forces

3.5.2 Ecosystem Dynamics – Value Chain Analysis

3.5.3 Macro Forces – PESTEL Breakdown

3.6 Price Trend Analysis

3.6.1 Regional Price Trend

3.6.2 Price Trend by product

CHAPTER NO. 4 :KEY INVESTMENT EPICENTER

4.1 Regional Goldmines – High-Growth Geographies

4.2 Product Frontiers – Lucrative Product Categories

4.3 Procedure Sweet Spots – Emerging Demand Segments

CHAPTER NO. 5: REVENUE TRAJECTORY & WEALTH MAPPING

5.1 Momentum Metrics – Forecast & Growth Curves

5.2 Regional Revenue Footprint – Market Share Insights

5.3 Segmental Wealth Flow – Product & Procedure Revenue

CHAPTER NO. 6 :TRADE & COMMERCE ANALYSIS

6.1.Import Analysis by Region

6.1.1. Global Structural Heart Devices Market Import Volume By Region

6.2.Export Analysis by Region

6.2.1. Global Structural Heart Devices Market Export Volume By Region

CHAPTER NO. 7 :COMPETITION ANALYSIS

7.1.Company Market Share Analysis

7.1.1. Global Structural Heart Devices Market: Company Market Share

7.1. Global Structural Heart Devices Market Company Volume Market Share

7.2. Global Structural Heart Devices Market Company Revenue Market Share

7.3.Strategic Developments

7.3.1.Acquisitions & Mergers

7.3.2. New Product Launch

7.3.3. Regional Expansion

7.4. Competitive Dashboard

7.5. Company Assessment Metrics, 2024

CHAPTER NO. 8 :STRUCTURAL HEART DEVICES MARKET – BY PRODUCT SEGMENT ANALYSIS

8.1.Structural Heart Devices Market Overview by Product Segment

8.1.1. Structural Heart Devices Market Volume Share By Product

8.1.2. Structural Heart Devices Market Revenue Share By Product

8.2. Heart Valve Devices

8.2.1Surgical Heart Valves

8.2.2Transcatheter Heart Valves

8.3. Annuloplasty Rings

8.4. Occluders and Delivery Systems

8.5.Other Products

CHAPTER NO. 9 :STRUCTURAL HEART DEVICES MARKET – BY PROCEDURE SEGMENT ANALYSIS

9.1.Structural Heart Devices Market Overview by Procedure Segment

9.1.1. Structural Heart Devices Market Volume Share By Procedure

9.1.2. Structural Heart Devices Market Revenue Share By Procedure

9.2. Replacement Procedures

9.2.1Surgical Aortic Valve Replacement (SAVR)

9.2.2 Transcatheter Aortic Valve Replacement (TAVR)

9.2.3 Transcatheter Mitral Valve Replacement (TMVR)

9.2.4 Other Replacement Procedures

9.3. Repair Procedures

9.3.1Left Atrial Appendage Closure (LAAC)

9.3.2 Transcatheter Mitral Valve Repair (Tmvr)

9.3.3 Transcatheter Tricuspid Valve Repair (Ttvr)

9.3.4 Valvuloplasty

9.3.5 Other Repair Procedures

CHAPTER NO. 10 :STRUCTURAL HEART DEVICES MARKET – BY END-USE SEGMENT ANALYSIS

10.1.Structural Heart Devices Market Overview by End-use Segment

10.1.1. Structural Heart Devices Market Volume Share By End-use

10.1.2. Structural Heart Devices Market Revenue Share By End-use

10.2. Hospitals

10.3. Ambulatory Surgical Centers

10.4. Cardiac Catheterization Labs

10.5. Other End Use

CHAPTER NO. 11 :STRUCTURAL HEART DEVICES MARKET – REGIONAL ANALYSIS

11.1.Structural Heart Devices Market Overview by Region Segment

11.1.1. Global Structural Heart Devices Market Volume Share By Region

11.1.2. Global Structural Heart Devices Market Revenue Share By Region

11.1.3.Regions

11.1.4.Global Structural Heart Devices Market Volume By Region

11.1.5.Global Structural Heart Devices Market Revenue By Region

11.1.6.Product

11.1.7.Global Structural Heart Devices Market Volume By Product

11.1.8.Global Structural Heart Devices Market Revenue By Product

11.1.9.Procedure

11.1.10. Global Structural Heart Devices Market Volume By Procedure

11.1.11. Global Structural Heart Devices Market Revenue By Procedure

11.1.12.End-use

11.1.13. Global Structural Heart Devices Market Volume By End-use

11.1.14. Global Structural Heart Devices Market Revenue By End-use

CHAPTER NO. 12 :NORTH AMERICA STRUCTURAL HEART DEVICES MARKET – COUNTRY ANALYSIS

12.1.North America Structural Heart Devices Market Overview by Country Segment

12.1.1.North America Structural Heart Devices Market Volume Share By Region

12.1.2. North America Structural Heart Devices Market Revenue Share By Region

12.2.North America

12.2.1.North America Structural Heart Devices Market Volume By Country

12.2.2.North America Structural Heart Devices Market Revenue By Country

12.2.3.Product

12.2.4.North America Structural Heart Devices Market Volume By Product

12.2.5.North America Structural Heart Devices Market Revenue By Product

12.2.6.Procedure

12.2.7.North America Structural Heart Devices Market Volume By Procedure

12.2.8. North America Structural Heart Devices Market Revenue By Procedure

12.2.9.End-use

12.2.10.North America Structural Heart Devices Market Volume By End-use

12.2.11.North America Structural Heart Devices Market Revenue By End-use

12.3.U.S.

12.4.Canada

12.5.Mexico

CHAPTER NO. 13 :EUROPE STRUCTURAL HEART DEVICES MARKET – COUNTRY ANALYSIS

13.1. Europe Structural Heart Devices Market Overview by Country Segment

13.1.1. Europe Structural Heart Devices Market Volume Share By Region

13.1.2. Europe Structural Heart Devices Market Revenue Share By Region

13.2.Europe

13.2.1.Europe Structural Heart Devices Market Volume By Country

13.2.2.Europe Structural Heart Devices Market Revenue By Country

13.2.3.Product

13.2.4.Europe Structural Heart Devices Market Volume By Product

13.2.5.Europe Structural Heart Devices Market Revenue By Product

13.2.6.Procedure

13.2.7. Europe Structural Heart Devices Market Volume By Procedure

13.2.8. Europe Structural Heart Devices Market Revenue By Procedure

13.2.9.End-use

13.2.10. Europe Structural Heart Devices Market Volume By End-use

13.2.11. Europe Structural Heart Devices Market Revenue By End-use

13.3.UK

13.4.France

13.5.Germany

13.6.Italy

13.7.Spain

13.8.Russia

13.9. Rest of Europe

CHAPTER NO. 14 :ASIA PACIFIC STRUCTURAL HEART DEVICES MARKET – COUNTRY ANALYSIS

14.1.Asia Pacific Structural Heart Devices Market Overview by Country Segment

14.1.1.Asia Pacific Structural Heart Devices Market Volume Share By Region

14.1.2.Asia Pacific Structural Heart Devices Market Revenue Share By Region

14.2.Asia Pacific

14.2.1. Asia Pacific Structural Heart Devices Market Volume By Country

14.2.2.Asia Pacific Structural Heart Devices Market Revenue By Country

14.2.3.Product

14.2.4.Asia Pacific Structural Heart Devices Market Volume By Product

14.2.5.Asia Pacific Structural Heart Devices Market Revenue By Product

14.2.6.Procedure

14.2.7.Asia Pacific Structural Heart Devices Market Volume By Procedure

14.2.8.Asia Pacific Structural Heart Devices Market Revenue By Procedure

14.2.9.End-use

14.2.10.Asia Pacific Structural Heart Devices Market Volume By End-use

14.2.11.Asia Pacific Structural Heart Devices Market Revenue By End-use

14.3.China

14.4.Japan

14.5.South Korea

14.6.India

14.7.Australia

14.8.Southeast Asia

14.9. Rest of Asia Pacific

CHAPTER NO. 15 : LATIN AMERICA STRUCTURAL HEART DEVICES MARKET – COUNTRY ANALYSIS

15.1.Latin America Structural Heart Devices Market Overview by Country Segment

15.1.1.Latin America Structural Heart Devices Market Volume Share By Region

15.1.2.Latin America Structural Heart Devices Market Revenue Share By Region

15.2. Latin America

15.2.1. Latin America Structural Heart Devices Market Volume By Country

15.2.2.Latin America Structural Heart Devices Market Revenue By Country

15.2.3.Product

15.2.4. Latin America Structural Heart Devices Market Volume By Product

15.2.5. Latin America Structural Heart Devices Market Revenue By Product

15.2.6.Procedure

15.2.7.Latin America Structural Heart Devices Market Volume By Procedure

15.2.8.Latin America Structural Heart Devices Market Revenue By Procedure

15.2.9.End-use

15.2.10.Latin America Structural Heart Devices Market Volume By End-use

15.2.11.Latin America Structural Heart Devices Market Revenue By End-use

15.3.Brazil

15.4.Argentina

15.5.Rest of Latin America

CHAPTER NO. 16 : MIDDLE EAST STRUCTURAL HEART DEVICES MARKET – COUNTRY ANALYSIS

16.1.Middle East Structural Heart Devices Market Overview by Country Segment

16.1.1.Middle East Structural Heart Devices Market Volume Share By Region

16.1.2. Middle East Structural Heart Devices Market Revenue Share By Region

16.2.Middle East

16.2.1. Middle East Structural Heart Devices Market Volume By Country

16.2.2.Middle East Structural Heart Devices Market Revenue By Country

16.2.3.Product

16.2.4.Middle East Structural Heart Devices Market Volume By Product

16.2.5.Middle East Structural Heart Devices Market Revenue By Product

16.2.6.Procedure

16.2.7.Middle East Structural Heart Devices Market Volume By Procedure

16.2.8.Middle East Structural Heart Devices Market Revenue By Procedure

16.2.9. End-use

16.2.10.Middle East Structural Heart Devices Market Volume By End-use

16.2.11. Middle East Structural Heart Devices Market Revenue By End-use

16.3.GCC Countries

16.4. Israel

16.5. Turkey

16.6.Rest of Middle East

CHAPTER NO. 17 : AFRICA STRUCTURAL HEART DEVICES MARKET – COUNTRY ANALYSIS

17.1. Africa Structural Heart Devices Market Overview by Country Segment

17.1.1.Africa Structural Heart Devices Market Volume Share By Region

17.1.2. Africa Structural Heart Devices Market Revenue Share By Region

17.2. Africa

17.2.1.Africa Structural Heart Devices Market Volume By Country

17.2.2.Africa Structural Heart Devices Market Revenue By Country

17.2.3.Product

17.2.4.Africa Structural Heart Devices Market Volume By Product

17.2.5.Africa Structural Heart Devices Market Revenue By Product

17.2.6.Procedure

17.2.7. Africa Structural Heart Devices Market Volume By Procedure

17.2.8. Africa Structural Heart Devices Market Revenue By Procedure

17.2.9.End-use

17.2.10. Africa Structural Heart Devices Market Volume By End-use

17.2.11. Africa Structural Heart Devices Market Revenue By End-use

17.3. South Africa

17.4.Egypt

17.5.Rest of Africa

CHAPTER NO. 18 :COMPANY PROFILES

18.1. Abbott

18.1.1.Company Overview

18.1.2.Product Portfolio

18.1.3.Financial Overview

18.1.4.Recent Developments

18.1.5.Growth Strategy

18.1.6.SWOT Analysis

18.2. AtriCure

18.3. BIOMERICS

18.4. Boston Scientific

18.5. BRAILE

18.6. CryoLife

18.7. Edwards

18.8. JENAVALVE

18.9. LEPU MEDICAL

18.10. LivaNova

18.11. Medtronic

18.12. NUMED

Request Sample

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Request Your Sample Report and Start Your Journey of Informed Choices

Providing the strategic compass for industry titans.

Frequently Asked Questions:

What is the current size of the Structural Heart Devices Market?

The Structural Heart Devices Market is valued at USD 6,683.01 million in 2024 and is projected to grow at a CAGR of 8.65%.

What are the key segments within the Structural Heart Devices Market?

Key segments include Heart Valve Devices, Replacement and Repair Procedures, and End-use sectors such as Hospitals and Cardiac Catheterization Labs.

What are some challenges faced by the Structural Heart Devices Market?

High device costs, complex regulatory approvals, and procedural complications are major challenges limiting broader adoption.

Who are the major players in the Structural Heart Devices Market?

Major players include Abbott, Medtronic, Boston Scientific, Edwards Lifesciences, and LivaNova.

About Author

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Related Reports By Keyword

Steel Structural Design Software Market

The Steel Structural Design Software Market is projected to grow from USD 1525.15 million in 2024 to USD 3038.9 million by 2032 at a compound annual growth rate of 9%.

Structural Health Monitoring Market

The Structural Health Monitoring Market size was valued at USD 1,950.00 million in 2018 to USD 3,643.84 million in 2024 and is anticipated to reach USD 13,856.86 million by 2032, at a CAGR of 18.22% during the forecast period.

Architectural and Structural Metals Market

The Architectural And Structural Metals Market is expected to grow from USD 643,220 million in 2024 to USD 907,744.3 million by 2032, with a compound annual growth rate (CAGR) of 4.4%.

Structural Health Monitoring Systems Market

Structural Health Monitoring Systems Market size was valued at USD 3,680 million in 2024 and is anticipated to reach USD 10,872 million by 2032, at a CAGR of 14.5% during the forecast period (2024-2032).

Advanced Structural Ceramics Market

The Advanced Structural Ceramics Market is projected to grow from USD 10,500 million in 2024 to USD 15,046.75 million by 2032, at a compound annual growth rate (CAGR) of 4.6%.

Automotive Structural Steel Market

The Automotive Structural Steel Market is projected to grow from USD 120,502 million in 2024 to USD 164,915.3 million by 2032, registering a compound annual growth rate (CAGR) of 4% during the forecast period.

Structural Battery Market

The Global Structural Battery Market is projected to grow from USD 170.19 million in 2024 to USD 808.24 million by 2032, at a CAGR of 21.50% from 2024 to 2032.

Silicon Structural Glazing Market

The Global Silicon Structural Glazing market is poised for substantial growth, projected to rise from USD 37,835.73 million in 2023 to an estimated USD 61,729.83 million by 2032. This growth represents a CAGR of 6.31% from 2024 to 2032.

Metal Structural Insulation Panels Market

The global demand for Metal Structural Insulation Panels Market was valued at USD 43.7 billion in 2023 and to reach USD 64.94 billion by 2032, growing at a CAGR of 4.50% between 2024 and 2032.

Purchase Options

Single User

$4999

Multi User

$6999

Enterprise

$12999

Let us help you

WILLIAM, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

LEE VALLANCE, Asia Pacific

+64 22 017 0275

KIERAN JAMESON, Australia

+61 4192 46279

Report delivery within 24 to 48 hours

What people say?

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Materials Scientist
(privacy requested)

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Management Assistant, Bekaert

Trusted By

Request Sample